Resvent's iBreeze and iBreeze+ Win the Red Dot Product Design Award 2026

The Red Dot Design Award often described as the “Oscar” of international design announced its 2026 winners this July, and two Resvent Medical devices are among them. The iBreeze CPAP/APAP and the portable iBreeze+ both received the Red Dot Award: Product Design 2026, a simultaneous double win that places Resvent among the recognized design leaders in respiratory therapy equipment worldwide.

According to Resvent, this achievement makes it the only home respiratory therapy device brand from China to hold two Red Dot awards, a milestone for the manufacturer, and a meaningful data point for the distributors, homecare providers, hospitals, and institutional procurement teams who evaluate and deploy CPAP and APAP machines at scale across Latin America.

What is the Red Dot Design Award?

The Red Dot Award: Product Design is one of the world’s largest and longest-running design competitions, with roots going back to 1954. Each year, an independent jury of approximately 40 international experts, designers, professors, and industry specialists, evaluates thousands of entries across 52 categories, from medical technology to consumer electronics.

What makes the award relevant beyond the design community is how products are judged. The jury assesses each entry individually, hands-on, against criteria that map closely to what procurement teams evaluate:

• Level of innovation: does the design solve a real problem in a new way?
• Functionality: does the product work as intended, for the people who actually use it?
• Formal quality: is the design coherent, well-executed, and free of superfluous complexity?
• Longevity: will the design hold up over time, both physically and conceptually?
• Ergonomics and self-explanatory quality: can users operate it intuitively, without extensive training?

Winning products earn the Red Dot label, a mark of design quality recognized across industries. Award-winning products are exhibited at the Red Dot Design Museum in Essen, Germany, and published in the Red Dot Design Yearbook, permanent, verifiable third-party recognition.

Why does a design award matter in B2B CPAP procurement?

It’s a fair question. Institutional buyers don’t purchase respiratory devices because they look good. But the dimensions the Red Dot jury evaluates (usability, durability, functional clarity) are precisely the dimensions that determine how a device performs after deployment:

Patient acceptance drives therapy adherence. In sleep therapy, the single biggest operational challenge is CPAP compliance. A device that patients perceive as clinical, intimidating, or complicated gets used less. Design quality directly affects whether a CPAP machine becomes part of a patient’s nightly routine or ends up unused and adherence rates are what homecare programs are measured on, including for reimbursement.

Intuitive operation reduces support costs. Every confused patient is a support call, a training session, or a device return. For a distributor managing hundreds or thousands of deployed units, ease of use is a real line item. Devices that elderly users, the largest demographic in sleep apnea therapy, can operate without assistance reduce the total cost of servicing a fleet.

Independent validation de-risks the purchasing decision. Procurement teams evaluating a manufacturer they know less well than ResMed or Philips need third-party evidence of quality. Regulatory certifications answer the safety question. An international design award, judged by an independent expert jury, answers a different one: has this manufacturer reached a world-class standard in how its products are engineered for real users? When a manufacturer wins for two devices simultaneously, that standard is systemic, not a one-off.

iBreeze: a flagship auto CPAP designed for adoption

The iBreeze CPAP/APAP, the platform many buyers already know through the iBreeze 20A Auto CPAP, earned its Red Dot for a design philosophy centered on the user from the outset. Each design decision has a downstream operational benefit for institutional deployment:

Minimalist design that integrates into the home

The iBreeze abandons the cold, clinical look of traditional medical equipment in favor of a streamlined, integrated form with a striking black-and-white color scheme. This is not cosmetic: devices that blend into a domestic environment reduce the anxiety many patients feel toward medical equipment, a documented barrier to therapy initiation. For homecare providers, higher acceptance at setup translates into higher usage in month three.

Intuitive human-machine interaction

A high-definition color display paired with a physical control dial provides clear, simple operating logic, designed so that even elderly users can manage the device with single-touch operations. Therapy data and device status are displayed visually and immediately, which simplifies patient education, shortens setup visits, and reduces the support burden on provider staff.

The iBreeze platform also carries the connectivity and clinical feature set institutional buyers require, auto-adjusting pressure algorithms, integrated humidification, and remote data capabilities for compliance monitoring across deployed fleets. Full specifications are on the iBreeze CPAP/APAP product page.

iBreeze+: portable CPAP therapy without compromising precision

The iBreeze+, Resvent’s portable model, was recognized for resolving a tension that has historically forced trade-offs: making a travel CPAP machine smaller usually means making it less capable. Its award-winning design combines:

An innovative compact, travel-ready structure. The iBreeze+ maintains full therapeutic capability in a significantly reduced footprint — relevant for homecare fleets serving mobile or traveling patients, and for markets where living space is limited.

Intelligent interaction and precise treatment. Upgraded smart algorithms and interaction systems automatically identify respiratory events and adjust pressure dynamically, optimizing patient-device synchronization. In practical terms: the device adapts to the patient breath by breath, improving comfort — and comfort is adherence.

For distributors, the iBreeze+ opens a portfolio segment, portable sleep therapy, that complements the stationary flagship without duplicating it. Details are on the iBreeze+ product page.

What does the double win mean for institutional buyers in Latin America?

For procurement teams across Mexico, Colombia, Argentina, Chile, and the wider region, the double Red Dot win adds an independent, verifiable data point to the supplier evaluation matrix:

• Verifiability. Red Dot publishes all winners in its public Winners Section at red-dot.org. This is not a manufacturer’s marketing claim, it can be checked in the source.
• Design maturity signals manufacturing maturity. Sustained investment in user-centered design and R&D is generally a proxy for the engineering discipline behind a product line, relevant when committing to a multi-year supplier relationship.
• A differentiation asset for distributors. If you distribute respiratory equipment, “Red Dot Award winner 2026” is a concrete, citable differentiator in your own commercial conversations with clinics and homecare programs, particularly against lesser-known alternatives.

Where to buy the award-winning iBreeze and iBreeze+ in Latin America

As the wholesale distribution channel for Resvent devices serving institutional buyers in Latin America, SysMed USA supplies the award-winning iBreeze and iBreeze+ with the technical documentation, regulatory support, and after-sales service that institutional procurement processes require.

Evaluating CPAP/APAP devices for your organization or portfolio? Request a quote or explore the full sleep therapy line.